The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
18F-FDG PET scan and liquid biopsy as tools to assess the pace of tumor progression and to predict overall survival (OS) in refractory colorectal cancer (rCRC): The CORIOLAN trial.
 
Silvia Camera
No Relationships to Disclose
 
Tugba Akin Telli
No Relationships to Disclose
 
Erwin Woff
No Relationships to Disclose
 
Pashalina Kehagias
No Relationships to Disclose
 
Thomas Guiot
No Relationships to Disclose
 
Gabriela Critchi
No Relationships to Disclose
 
Giacomo Bregni
No Relationships to Disclose
 
Elena Trevisi
No Relationships to Disclose
 
Andrea Pretta
No Relationships to Disclose
 
Amélie Deleruelle
No Relationships to Disclose
 
Chiara Senti
No Relationships to Disclose
 
Sophia Leduc
No Relationships to Disclose
 
Leila Shaza
No Relationships to Disclose
 
Frédéric Hoerner
No Relationships to Disclose
 
Caroline Vandeputte
No Relationships to Disclose
 
Francesco Sclafani
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly
 
Patrick Flamen
No Relationships to Disclose
 
Alain Hendlisz
No Relationships to Disclose
 
Amélie Deleporte
No Relationships to Disclose
 
Francoise Rothe
No Relationships to Disclose